Both in Pharmaceuticals
Valion Bio vs PMGC Holdings
Over the past year VBIO returned −77.1% and ELAB returned −57.5%; their daily moves had a correlation of -0.09.
VBIO −77.1% ELAB −57.5%Growth of $1, one year, split-adjusted
| Metric | VBIO | ELAB |
|---|---|---|
| Price | $0.5171 | $1.92 |
| Market cap | $1.1M | $1.6M |
| Today | −2.60% | −1.03% |
| 1 month | −78.3% | −41.3% |
| 6 months | — | −91.0% |
| Year to date | — | −99.5% |
| 1 year | — | −99.9% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | 29.5% |
| Net margin | — | −225.1% |
| P/E (TTM) | — | — |
| Price / sales | — | 0.6× |
| Net cash | -$5.3M | $9.4M |
| Dividend yield | — | — |
| Volatility (60d) | — | 677.7% |
| Short % of float | 9.0% | 0.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).